AI주식인사이트AI Stock Insight
C

오상헬스케어

036220KOSDAQ의료용 기기 제조업

46.5 / 100

Reference Date: 2026-07-24

Financial Score18.0 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Rose 5.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Osang Healthcare is a company specializing in in vitro diagnostics (IVD), developing and selling biochemical, immunoassay, and molecular diagnostic products, including blood glucose meters, HbA1c devices, and cholesterol meters. It operates subsidiaries in the US and Brazil to expand its global market and is also pursuing new ventures in bio-healthcare.

Number of Employees

336people

Average Salary

57.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
26.77Industry Average 20.043.0Point

Higher than industry avg (caution)

PBR
0.31Industry Average 1.147.0Point

Half of industry avg (excellent)

ROE
1.10Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
10.95Industry Average 11.654.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼8.8% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼3.8% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 14.8% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 6,050Won52-week high 19,24052-week low 5,390
1-month return4.0Point

1m +5.77% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0